arrow
Q

Qianwen Wang

GlaxoSmithKline
H指数:20
被引数:2,969

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Open-Label Phase II Trial of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 Infection in Immunocompromised Individuals with Impaired SARS-CoV-2 Humoral Immunity

一项关于Sotrovimab(VIR-7831)预防COVID-19感染的开放标签II期临床试验,研究对象为SARS-CoV-2体液免疫受损的免疫抑制个体

2025-08-080
OAAI
The effects of pulsed electromagnetic field therapy on muscle strength and pain in patients with end-stage knee osteoarthritis: a randomized controlled trial

脉冲电磁场治疗对终末期膝骨关节炎患者肌肉力量和疼痛的影响: 一项随机对照试验

2024-10-161
OAAI